Patients who take the autoimmune disease treatment Humira may see some price relief when several lower-cost, biosimilar versions of the AbbVie drug reach the U.S. market in July.
But lower pharmacy bills may not happen right away — or at all — for some patients. That'll depend largely on your insurance coverage. Here’s a closer look.
